MedTrace Logo

Development of an Online ACT Intervention for Disorders of Gut-Brain Interaction

NCT06309004 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-08-15

No results posted yet for this study

Summary

The goal of this clinical trial is to develop and test the iACTforDGBI intervention in a sample of Swedish individuals with DGBI (Disorders of Gut-Brain Interaction).

The first substudy of this project (Substudy 1) aims to answer the following question: How can the design of iACTforDGBI be tailored to meet the specific needs of individuals with DGBI and clinically meaningful symptoms of anxiety and depression?

Participants (individuals with symptoms compatible with a DGBI and anxiety and/or depression, and healthcare professionals working with DGBI patients) will be asked to participate in online focus-group interviews and provide information on their views of a preliminary version of the iACTforDGBi intervention.

Conditions

  • Anxiety and Depression
  • Disorders of Gut-brain Interaction

Sponsors & Collaborators

  • Uppsala University

    collaborator OTHER

  • SahlgrenskaUniversityHospital

    collaborator UNKNOWN

  • Göteborg University

    collaborator OTHER

  • Örebro University, Sweden

    lead OTHER

Principal Investigators

  • Inês A Trindade, PhD · Örebro University, Sweden

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-23
Primary Completion
2025-08-31
Completion
2025-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06309004 on ClinicalTrials.gov